Chunxia Su
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| SHR0302 Combined With PD-1/PD-L1 Inhibition for Treatment naïve or Acquired Resistant to Immunology NSCLC (NCT06925048) | Chunxia Su | 2025-04-30 |
Track Chunxia Su automatically
Every clearance here is in the API, with alerts when new ones post.